Bruce Levine, CAR-T therapies, Carl June, Gilead, Kite, Tmunity Therapeutic, University of Pennsylvania
Kite completes acquisition of Tmunity
Press Release Feb 2023: - Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire Tmunity Therapeutics (Tmunity), a clinical-stage, private biotech compan..
Patrick Wen, Penn medicine, UCLA lab, University of Pennsylvania, VEGF
CAR T-Cell therapy in solid tumors – A research study
March 2022: Blood vessels are supposed to behave like trees, pouring oxygen into tissues in order for them to flourish and immune cells to clean infections out. The forest, on the other hand, can go awry in tumours. Vessels expand..
China, Chongqing, Professor Qian Cheng, University of Pennsylvania
Patient in China achieves complete remission from leukemia after CAR T-Cell therapy
Feb 2022: In China, a patient whose life was on the verge of ending was entirely healed of leukaemia thanks to CAR T-cell therapy, which stimulated the immune system. All cancer cells vanished swiftly in the first study of its kin..